Global Aldesleukin Market Professional Survey Report 2019
Aldesleukin, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleu...
$3,500.00 04 October, 2019 | QYResearch
Global Aldesleukin Market Professional Survey Report 2019
$3,500.00 | 04 October, 2019 | QYResearch
Aldesleukin, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the huma...
Global Lanreotide Market Professional Survey Report 2019
Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome The glob...
$3,500.00 04 October, 2019 | QYResearch
Global Lanreotide Market Professional Survey Report 2019
$3,500.00 | 04 October, 2019 | QYResearch
Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome...
Global Pegvisomant Market Professional Survey Report 2019
Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global Pegvisomant market was valued at xx...
$3,500.00 04 October, 2019 | QYResearch
Global Pegvisomant Market Professional Survey Report 2019
$3,500.00 | 04 October, 2019 | QYResearch
Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global Pegvisomant market was va...
Global Acromegaly Therapeutics Market Professional Survey Report 2019
Acromegaly is a disorder that results from excess growth hormone (GH) after the growth plates have closed. In this report, we study the drugs for Acromegaly....
$3,500.00 04 October, 2019 | QYResearch
Global Acromegaly Therapeutics Market Professional Survey Report 2019
$3,500.00 | 04 October, 2019 | QYResearch
Acromegaly is a disorder that results from excess growth hormone (GH) after the growth plates have closed. In this report, we study the drugs for A...
Global Besponsa Market Professional Survey Report 2019
Besponsa is an antibody-drug conjugate used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The global Besponsa market ...
$3,500.00 04 October, 2019 | QYResearch
Global Besponsa Market Professional Survey Report 2019
$3,500.00 | 04 October, 2019 | QYResearch
Besponsa is an antibody-drug conjugate used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The global Bespon...
Global Gemtuzumab Ozogamicin Drugs Market Professional Survey Report 2019
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010. The...
$3,500.00 04 October, 2019 | QYResearch
Global Gemtuzumab Ozogamicin Drugs Market Professional Survey Report 2019
$3,500.00 | 04 October, 2019 | QYResearch
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to ...
Global Trisenox Market Professional Survey Report 2019
Trisenox is a chemotherapy drug and is also called Trisenox or ATO. It is a treatment for a type of acute myeloid leukaemia called acute promyelocytic leukae...
$3,500.00 04 October, 2019 | QYResearch
Global Trisenox Market Professional Survey Report 2019
$3,500.00 | 04 October, 2019 | QYResearch
Trisenox is a chemotherapy drug and is also called Trisenox or ATO. It is a treatment for a type of acute myeloid leukaemia called acute promyelocy...
Global Revcovi Market Professional Survey Report 2019
Revcovi is indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients. The global Revco...
$3,500.00 04 October, 2019 | QYResearch
Global Revcovi Market Professional Survey Report 2019
$3,500.00 | 04 October, 2019 | QYResearch
Revcovi is indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients. The gl...
Global Ebola Treatment Market Professional Survey Report 2019
Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called Zaire) in 1976. Ebola is a viral disease which frequ...
$3,500.00 04 October, 2019 | QYResearch
Global Ebola Treatment Market Professional Survey Report 2019
$3,500.00 | 04 October, 2019 | QYResearch
Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called Zaire) in 1976. Ebola is a viral disease w...
Global Multiple Sclerosis Therapeutics Market Professional Survey Report 2019
Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protec...
$3,500.00 04 October, 2019 | QYResearch
Global Multiple Sclerosis Therapeutics Market Professional Survey Report 2019
$3,500.00 | 04 October, 2019 | QYResearch
Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks ...